Management of movement disorders in glutaryl-CoA dehydrogenase deficiency anticholinergic drugs and botulinum toxin as additional therapeutic options 2004
Management of movement disorders in glutaryl-CoA dehydrogenase deficiency anticholinergic drugs and botulinum toxin as additional therapeutic options 2004...
25 julio, 2019
/ 0 Comentario